PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: MARKET SEGMENTATION BY END-USER Market segmentation by end-user Comparison by end-user Pharmaceutical and biotechnology industry - Market size and forecast 2018-2023 Food and beverage industry - Market size and forecast 2018-2023 Cosmetic industry - Market size and forecast 2018-2023 Others - Market size and forecast 2018-2023 Market opportunity by end-user PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 09: DRIVERS AND CHALLENGES Market drivers Market challenges PART 10: MARKET TRENDS Use of affinity chromatography in vaccine manufacturing Increasing focus on advanced, faster, and cost-effective purification technologies Increasing demand for purification in immunotherapies PART 11: VENDOR LANDSCAPE Overview Landscape disruption PART 12: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors Agilent Technologies Inc. Bio-Rad Laboratories Inc. General Electric Co. Merck KGaA Thermo Fisher Scientific Inc. PART 13: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 14: EXPLORE TECHNAVIO   Exhibit 01: Product overview Exhibit 02: Global healthcare market Exhibit 03: Segments of global healthcare market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: End-user - Market share 2018-2023 (%) Exhibit 19: Comparison by end-user Exhibit 20: Pharmaceutical and biotechnology industry - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Pharmaceutical and biotechnology industry - Year-over-year growth 2019-2023 (%) Exhibit 22: Food and beverage industry - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Food and beverage industry - Year-over-year growth 2019-2023 (%) Exhibit 24: Cosmetic industry - Market size and forecast 2018-2023 ($ millions) Exhibit 25: Cosmetic industry - Year-over-year growth 2019-2023 (%) Exhibit 26: Others - Market size and forecast 2018-2023 ($ millions) Exhibit 27: Others - Year-over-year growth 2019-2023 (%) Exhibit 28: Market opportunity by end-user Exhibit 29: Customer landscape Exhibit 30: Market share by geography 2018-2023 (%) Exhibit 31: Geographic comparison Exhibit 32: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 33: North America - Year-over-year growth 2019-2023 (%) Exhibit 34: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 35: Europe - Year-over-year growth 2019-2023 (%) Exhibit 36: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 37: Asia - Year-over-year growth 2019-2023 (%) Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 39: ROW - Year-over-year growth 2019-2023 (%) Exhibit 40: Key leading countries Exhibit 41: Market opportunity Exhibit 42: Impact of drivers and challenges Exhibit 43: Vendor landscape Exhibit 44: Landscape disruption Exhibit 45: Vendors covered Exhibit 46: Vendor classification Exhibit 47: Market positioning of vendors Exhibit 48: Agilent Technologies Inc. - Vendor overview Exhibit 49: Agilent Technologies Inc. - Business segments Exhibit 50: Agilent Technologies Inc. - Organizational developments Exhibit 51: Agilent Technologies Inc. - Geographic focus Exhibit 52: Agilent Technologies Inc. - Segment focus Exhibit 53: Agilent Technologies Inc. - Key offerings Exhibit 54: Bio-Rad Laboratories Inc. - Vendor overview Exhibit 55: Bio-Rad Laboratories Inc. - Business segments Exhibit 56: Bio-Rad Laboratories Inc. - Organizational developments Exhibit 57: Bio-Rad Laboratories Inc. - Geographic focus Exhibit 58: Bio-Rad Laboratories Inc. - Segment focus Exhibit 59: Bio-Rad Laboratories Inc. - Key offerings Exhibit 60: General Electric Co. - Vendor overview Exhibit 61: General Electric Co. - Business segments Exhibit 62: General Electric Co. - Organizational developments Exhibit 63: General Electric Co. - Geographic focus Exhibit 64: General Electric Co. - Segment focus Exhibit 65: General Electric Co. - Key offerings Exhibit 66: Merck KGaA - Vendor overview Exhibit 67: Merck KGaA - Business segments Exhibit 68: Merck KGaA - Organizational developments Exhibit 69: Merck KGaA - Geographic focus Exhibit 70: Merck KGaA - Segment focus Exhibit 71: Merck KGaA - Key offerings Exhibit 72: Thermo Fisher Scientific Inc. - Vendor overview Exhibit 73: Thermo Fisher Scientific Inc. - Business segments Exhibit 74: Thermo Fisher Scientific Inc. - Organizational developments Exhibit 75: Thermo Fisher Scientific Inc. - Geographic focus Exhibit 76: Thermo Fisher Scientific Inc. - Segment focus Exhibit 77: Thermo Fisher Scientific Inc. - Key offerings Exhibit 78: Validation techniques employed for market sizing Exhibit 79: Definition of market positioning of vendors

Agilent Technologies Inc., Bio-Rad Laboratories Inc., General Electric Co., Merck KGaA, and Thermo Fisher Scientific Inc.